Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2018, Article ID 3793768, 6 pages
https://doi.org/10.1155/2018/3793768
Research Article

Assessment of the Relationship between Carotid Intima-Media Thickening and Early-Stage Diabetic Kidney Disease Coupled with Helicobacter pylori Infection

1Graduate School, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China
2Emergency Department, Chongqing Steel Group General Hospital, Chongqing 400037, China
3Hospital Infection Control Department, Suining Central Hospital, Suining 629000, China

Correspondence should be addressed to Lei Feng; moc.361@228ielgnef

Received 14 November 2017; Accepted 19 March 2018; Published 16 April 2018

Academic Editor: Mariann Harangi

Copyright © 2018 Lei Feng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. M. Weyand, G. J. Berry, and J. J. Goronzy, “The immunoinhibitory PD-1/PD-L1 pathway in inflammatory blood vessel disease,” Journal of Leukocyte Biology, pp. jlb.3MA0717–jlb.3MA0283, 2017. View at Publisher · View at Google Scholar
  2. E. Bartoloni, A. Alunno, and R. Gerli, “Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases,” Nature Reviews Cardiology, vol. 15, no. 1, pp. 33–44, 2017. View at Publisher · View at Google Scholar · View at Scopus
  3. J. S. Kim and O. Y. Bang, “Medical treatment of intracranial atherosclerosis: an update,” Journal of Stroke, vol. 19, no. 3, pp. 261–270, 2017. View at Publisher · View at Google Scholar · View at Scopus
  4. D. H. O'Leary, J. F. Polak, R. A. Kronmal et al., “Distribution and correlates of sonographically detected carotid artery disease in the cardiovascular health study. The CHS Collaborative Research Group,” Stroke, vol. 23, no. 12, pp. 1752–1760, 1992. View at Publisher · View at Google Scholar
  5. M. Hirano, T. Nakamura, Y. Kitta et al., “Assessment of carotid plaque echolucency in addition to plaque size increases the predictive value of carotid ultrasound for coronary events in patients with coronary artery disease and mild carotid atherosclerosis,” Atherosclerosis, vol. 211, no. 2, pp. 451–455, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Yamasaki, M. Kodama, H. Nishizawa et al., “Carotid intima-media thickness in Japanese type 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease,” Diabetes Care, vol. 23, no. 9, pp. 1310–1315, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. D. K. Packham, T. P. Alves, J. P. Dwyer et al., “Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database,” American Journal of Kidney Diseases, vol. 59, no. 1, pp. 75–83, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Hovind, P. Rossing, L. Tarnow, U. M. Smidt, and H. H. Parving, “Progression of diabetic nephropathy,” Kidney International, vol. 59, no. 2, pp. 702–709, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. H. H. Parving, “Diabetic nephropathy: prevention and treatment,” Kidney International, vol. 60, no. 5, pp. 2041–2055, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Flyvbjerg, “The role of the complement system in diabetic nephropathy,” Nature Reviews Nephrology, vol. 13, no. 5, pp. 311–318, 2017. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Yamamoto, J. Zhong, P. G. Yancey et al., “Atherosclerosis following renal injury is ameliorated by pioglitazone and losartan via macrophage phenotype,” Atherosclerosis, vol. 242, no. 1, pp. 56–64, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. S. J. Jenks, B. R. Conway, S. McLachlan et al., “Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes,” Diabetologia, vol. 60, no. 8, pp. 1400–1408, 2017. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Ghadirpour, M. K. Tarzamni, M. Naghavi-Behzad, S. Abedi-Azar, H. Koushavar, and N. Nezami, “Renal vascular Doppler ultrasonographic indices and carotid artery intima-media thickness in diabetic nephropathy,” Medical Ultrasonography, vol. 16, no. 2, pp. 95–99, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Tavridou, A. Georgoulidou, A. Roumeliotis et al., “Association of plasma adiponectin and oxidized low-density lipoprotein with carotid intima-media thickness in diabetic nephropathy,” Journal of Diabetes Research, vol. 2015, Article ID 507265, 8 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Y. Chou, C. J. Liu, T. F. Chao et al., “Presence of diabetic microvascular complications does not incrementally increase risk of ischemic stroke in diabetic patients with atrial fibrillation: a nationwide cohort study,” Medicine, vol. 95, no. 27, article e3992, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. M. S. McClain, A. C. Beckett, and T. L. Cover, “Helicobacter pylori vacuolating toxin and gastric cancer,” Toxins, vol. 9, no. 12, p. 316, 2017. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Basyigit, H. Akbas, I. Suleymanlar, D. Kemaloglu, S. Koç, and G. Suleymanlar, “The assessment of carotid intima-media thickness, lipid profiles and oxidative stress markers in Helicobacter pylori-positive subjects,” The Turkish Journal of Gastroenterology, vol. 23, no. 6, pp. 646–651, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. C. He, Z. Yang, and N. H. Lu, “Helicobacter pylori-an infectious risk factor for atherosclerosis?” Journal of Atherosclerosis and Thrombosis, vol. 21, no. 12, pp. 1229–1242, 2014. View at Google Scholar
  19. E. Altintas, E. Ucbilek, O. Ulu et al., “Helicobacter pylori-associated atrophic gastritis and carotid intima-media thickness: is there a link?” International Journal of Clinical Practice, vol. 61, no. 5, pp. 810–814, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. A. R. Folsom, F. J. Nieto, P. Sorlie, L. E. Chambless, and D. Y. Graham, “Helicobacter pylori seropositivity and coronary heart disease incidence,” Circulation, vol. 98, no. 9, pp. 845–850, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Wu, X. Li, Y. Tao, Y. Wang, and Y. Peng, “Free triiodothyronine levels are associated with diabetic nephropathy in euthyroid patients with type 2 diabetes,” International Journal of Endocrinology, vol. 2015, Article ID 204893, 7 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Lv, W. Sun, X. Huang et al., “Association of serum fetuin-A levels with the risk of albuminuria in middle-aged and elderly Chinese,” The Journal of Clinical Endocrinology and Metabolism, vol. 101, no. 3, pp. 1235–1242, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Khadangi, M. Yassi, and M. A. Kerachian, “Review: diagnostic accuracy of PCR-based detection tests for Helicobacter pylori in stool samples,” Helicobacter, vol. 22, no. 6, article e12444, 2017. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Xu, L. Wang, J. He et al., “Prevalence and control of diabetes in Chinese adults,” JAMA, vol. 310, no. 9, pp. 948–959, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Zhang, Y. Wang, R. Zhang et al., “Implication of decreased serum complement 3 in patients with diabetic nephropathy,” Acta Diabetologica, vol. 55, no. 1, pp. 31–39, 2018. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Ito, Y. Komatsu, M. Mifune et al., “The estimated GFR, but not the stage of diabetic nephropathy graded by the urinary albumin excretion, is associated with the carotid intima-media thickness in patients with type 2 diabetes mellitus: a cross-sectional study,” Cardiovascular Diabetology, vol. 9, no. 1, p. 18, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Barrios, J. Pascual, S. Otero et al., “Diabetic nephropathy is an independent factor associated to severe subclinical atheromatous disease,” Atherosclerosis, vol. 242, no. 1, pp. 37–44, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. S. A. Hamed, N. F. Amine, G. M. Galal et al., “Vascular risks and complications in diabetes mellitus: the role of Helicobacter pylori infection,” Journal of Stroke and Cerebrovascular Diseases, vol. 17, no. 2, pp. 86–94, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Xu, Q. Wang, Y. Liu, R. Cui, K. Lu, and Y. Zhao, “Association between Helicobacter pylori infection and carotid atherosclerosis in patients with vascular dementia,” Journal of the Neurological Sciences, vol. 362, pp. 73–77, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. H. S. Akbas, S. Basyigit, I. Suleymanlar et al., “The assessment of carotid intima media thickness and serum paraoxonase-1 activity in Helicobacter pylori positive subjects,” Lipids in Health and Disease, vol. 9, no. 1, p. 92, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. H. S. Markus, P. Risley, M. A. Mendall, H. Steinmetz, and M. Sitzer, “Helicobacter pylori infection, the cytotoxin gene A strain, and carotid artery intima-media thickness,” European Journal of Cardiovascular Prevention & Rehabilitation, vol. 9, no. 1, pp. 1–6, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Köksal, Y. Ekmekçi, Y. Karadeniz et al., “Helicobacter pylori seropositivity and atherosclerosis risk factors,” Digestive Diseases, vol. 22, no. 4, pp. 386–389, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Gökçe, Z. Atbinici, Z. Aycan, H. G. Çınar, and P. Zorlu, “The relationship between pediatric nonalcoholic fatty liver disease and cardiovascular risk factors and increased risk of atherosclerosis in obese children,” Pediatric Cardiology, vol. 34, no. 2, pp. 308–315, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Kanda, M. Ai, M. Okazaki, M. Yoshida, and Y. Maeda, “Association of high-density lipoprotein subclasses with chronic kidney disease progression, atherosclerosis, and Klotho,” PLoS One, vol. 11, no. 11, article e0166459, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Laurila, A. Bloigu, S. Näyhä, J. Hassi, M. Leinonen, and P. Saikku, “Association of Helicobacter pylori infection with elevated serum lipids,” Atherosclerosis, vol. 142, no. 1, pp. 207–210, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Niemela, T. Karttunen, T. Korhonen et al., “Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations?” Heart, vol. 75, no. 6, pp. 573–575, 1996. View at Publisher · View at Google Scholar
  37. I. Tabas and A. H. Lichtman, “Monocyte-macrophages and T cells in atherosclerosis,” Immunity, vol. 47, no. 4, pp. 621–634, 2017. View at Publisher · View at Google Scholar · View at Scopus
  38. N. V. K. Pothineni, S. Subramany, K. Kuriakose et al., “Infections, atherosclerosis, and coronary heart disease,” European Heart Journal, vol. 38, no. 43, pp. 3195–3201, 2017. View at Publisher · View at Google Scholar
  39. M. S. Miraghajani, A. Esmaillzadeh, M. M. Najafabadi, M. Mirlohi, and L. Azadbakht, “Soy milk consumption, inflammation, coagulation, and oxidative stress among type 2 diabetic patients with nephropathy,” Diabetes Care, vol. 35, no. 10, pp. 1981–1985, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. Z. Yildirim, B. Bozkurt, D. Ozol et al., “Increased exhaled 8-isoprostane and interleukin-6 in patients with Helicobacter pylori infection,” Helicobacter, vol. 21, no. 5, pp. 389–394, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Banerjee, S. Thamphiwatana, E. M. Carmona, B. Rickman, K. S. Doran, and M. Obonyo, “Deficiency of the myeloid differentiation primary response molecule MyD88 leads to an early and rapid development of Helicobacter-induced gastric malignancy,” Infection and Immunity, vol. 82, no. 1, pp. 356–363, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. A. J. Kattoor, N. V. K. Pothineni, D. Palagiri, and J. L. Mehta, “Oxidative stress in atherosclerosis,” Current Atherosclerosis Reports, vol. 19, no. 11, p. 42, 2017. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Zeng, C.-L. Zhang, N. Zhao et al., “Impairment of Akt activity by CYP2E1 mediated oxidative stress is involved in chronic ethanol-induced fatty liver,” Redox Biology, vol. 14, pp. 295–304, 2018. View at Publisher · View at Google Scholar · View at Scopus
  44. P. G. Khatami, A. Soleimani, N. Sharifi, E. Aghadavod, and Z. Asemi, “The effects of high-dose vitamin E supplementation on biomarkers of kidney injury, inflammation, and oxidative stress in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial,” Journal of Clinical Lipidology, vol. 10, no. 4, pp. 922–929, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. G. Vijayan, R. C. Sundaram, Z. Bobby, A. Hamide, N. Selvaraj, and N. R. Dasse, “Increased plasma malondialdehyde and fructosamine in anemic H. pylori infected patients: effect of treatment,” World Journal of Gastroenterology, vol. 13, no. 5, pp. 796–800, 2007. View at Publisher · View at Google Scholar